MAPT and Alzheimer disease: In post-mortem brains from AD patients, tau phosphorylation was found to increase at several GSK-3β directed epitopes such as AT8, AT180, AT100, and PHF1 (Ishiguro et al., 1992; Armstrong, 2006).